Copyright Reports & Markets. All rights reserved.

Global FPR1 Inhibitor Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global FPR1 Inhibitor Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 FPR1 Antagonists
    • 1.3.3 Indirect Inhibitors
    • 1.3.4 Antibody Blockers
    • 1.3.5 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global FPR1 Inhibitor Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Pharma/Biotech
    • 1.4.3 Research
    • 1.4.4 Other
  • 1.5 Global FPR1 Inhibitor Market Size & Forecast
    • 1.5.1 Global FPR1 Inhibitor Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global FPR1 Inhibitor Sales Quantity (2021-2032)
    • 1.5.3 Global FPR1 Inhibitor Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Merck
    • 2.1.1 Merck Details
    • 2.1.2 Merck Major Business
    • 2.1.3 Merck FPR1 Inhibitor Product and Services
    • 2.1.4 Merck FPR1 Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Merck Recent Developments/Updates
  • 2.2 Bio-Techne
    • 2.2.1 Bio-Techne Details
    • 2.2.2 Bio-Techne Major Business
    • 2.2.3 Bio-Techne FPR1 Inhibitor Product and Services
    • 2.2.4 Bio-Techne FPR1 Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Bio-Techne Recent Developments/Updates
  • 2.3 Abcam
    • 2.3.1 Abcam Details
    • 2.3.2 Abcam Major Business
    • 2.3.3 Abcam FPR1 Inhibitor Product and Services
    • 2.3.4 Abcam FPR1 Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Abcam Recent Developments/Updates
  • 2.4 ApexBio Technology
    • 2.4.1 ApexBio Technology Details
    • 2.4.2 ApexBio Technology Major Business
    • 2.4.3 ApexBio Technology FPR1 Inhibitor Product and Services
    • 2.4.4 ApexBio Technology FPR1 Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 ApexBio Technology Recent Developments/Updates
  • 2.5 TargetMol Chemicals
    • 2.5.1 TargetMol Chemicals Details
    • 2.5.2 TargetMol Chemicals Major Business
    • 2.5.3 TargetMol Chemicals FPR1 Inhibitor Product and Services
    • 2.5.4 TargetMol Chemicals FPR1 Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 TargetMol Chemicals Recent Developments/Updates
  • 2.6 GLPBio
    • 2.6.1 GLPBio Details
    • 2.6.2 GLPBio Major Business
    • 2.6.3 GLPBio FPR1 Inhibitor Product and Services
    • 2.6.4 GLPBio FPR1 Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 GLPBio Recent Developments/Updates
  • 2.7 ProbeChem Biochemicals
    • 2.7.1 ProbeChem Biochemicals Details
    • 2.7.2 ProbeChem Biochemicals Major Business
    • 2.7.3 ProbeChem Biochemicals FPR1 Inhibitor Product and Services
    • 2.7.4 ProbeChem Biochemicals FPR1 Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 ProbeChem Biochemicals Recent Developments/Updates
  • 2.8 MedChemExpress
    • 2.8.1 MedChemExpress Details
    • 2.8.2 MedChemExpress Major Business
    • 2.8.3 MedChemExpress FPR1 Inhibitor Product and Services
    • 2.8.4 MedChemExpress FPR1 Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 MedChemExpress Recent Developments/Updates

3 Competitive Environment: FPR1 Inhibitor by Manufacturer

  • 3.1 Global FPR1 Inhibitor Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global FPR1 Inhibitor Revenue by Manufacturer (2021-2026)
  • 3.3 Global FPR1 Inhibitor Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of FPR1 Inhibitor by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 FPR1 Inhibitor Manufacturer Market Share in 2025
    • 3.4.3 Top 6 FPR1 Inhibitor Manufacturer Market Share in 2025
  • 3.5 FPR1 Inhibitor Market: Overall Company Footprint Analysis
    • 3.5.1 FPR1 Inhibitor Market: Region Footprint
    • 3.5.2 FPR1 Inhibitor Market: Company Product Type Footprint
    • 3.5.3 FPR1 Inhibitor Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global FPR1 Inhibitor Market Size by Region
    • 4.1.1 Global FPR1 Inhibitor Sales Quantity by Region (2021-2032)
    • 4.1.2 Global FPR1 Inhibitor Consumption Value by Region (2021-2032)
    • 4.1.3 Global FPR1 Inhibitor Average Price by Region (2021-2032)
  • 4.2 North America FPR1 Inhibitor Consumption Value (2021-2032)
  • 4.3 Europe FPR1 Inhibitor Consumption Value (2021-2032)
  • 4.4 Asia-Pacific FPR1 Inhibitor Consumption Value (2021-2032)
  • 4.5 South America FPR1 Inhibitor Consumption Value (2021-2032)
  • 4.6 Middle East & Africa FPR1 Inhibitor Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global FPR1 Inhibitor Sales Quantity by Type (2021-2032)
  • 5.2 Global FPR1 Inhibitor Consumption Value by Type (2021-2032)
  • 5.3 Global FPR1 Inhibitor Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global FPR1 Inhibitor Sales Quantity by Application (2021-2032)
  • 6.2 Global FPR1 Inhibitor Consumption Value by Application (2021-2032)
  • 6.3 Global FPR1 Inhibitor Average Price by Application (2021-2032)

7 North America

  • 7.1 North America FPR1 Inhibitor Sales Quantity by Type (2021-2032)
  • 7.2 North America FPR1 Inhibitor Sales Quantity by Application (2021-2032)
  • 7.3 North America FPR1 Inhibitor Market Size by Country
    • 7.3.1 North America FPR1 Inhibitor Sales Quantity by Country (2021-2032)
    • 7.3.2 North America FPR1 Inhibitor Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe FPR1 Inhibitor Sales Quantity by Type (2021-2032)
  • 8.2 Europe FPR1 Inhibitor Sales Quantity by Application (2021-2032)
  • 8.3 Europe FPR1 Inhibitor Market Size by Country
    • 8.3.1 Europe FPR1 Inhibitor Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe FPR1 Inhibitor Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific FPR1 Inhibitor Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific FPR1 Inhibitor Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific FPR1 Inhibitor Market Size by Region
    • 9.3.1 Asia-Pacific FPR1 Inhibitor Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific FPR1 Inhibitor Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America FPR1 Inhibitor Sales Quantity by Type (2021-2032)
  • 10.2 South America FPR1 Inhibitor Sales Quantity by Application (2021-2032)
  • 10.3 South America FPR1 Inhibitor Market Size by Country
    • 10.3.1 South America FPR1 Inhibitor Sales Quantity by Country (2021-2032)
    • 10.3.2 South America FPR1 Inhibitor Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa FPR1 Inhibitor Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa FPR1 Inhibitor Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa FPR1 Inhibitor Market Size by Country
    • 11.3.1 Middle East & Africa FPR1 Inhibitor Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa FPR1 Inhibitor Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 FPR1 Inhibitor Market Drivers
  • 12.2 FPR1 Inhibitor Market Restraints
  • 12.3 FPR1 Inhibitor Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of FPR1 Inhibitor and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of FPR1 Inhibitor
  • 13.3 FPR1 Inhibitor Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 FPR1 Inhibitor Typical Distributors
  • 14.3 FPR1 Inhibitor Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global FPR1 Inhibitor market size was valued at US$ 45.76 million in 2025 and is forecast to a readjusted size of US$ 56.96 million by 2032 with a CAGR of 3.2% during review period.
    In 2024, the global production of FPR1 inhibitors reached 3,076 grams, with an average selling price of US$14 per mg.
    FPR1 inhibitor is a compound or substance used to inhibit the activity of FPR1 (Formyl Peptide Receptor 1, N-formyl peptide receptor 1). FPR1 is a G protein-coupled receptor that is involved in regulating biological processes such as inflammation, immunity, and cell migration. FPR1 inhibitors bind to FPR1 and block its signaling pathway, thereby inhibiting its related biological responses. These inhibitors are often used in scientific research to explore the role of FPR1 in physiological and pathological processes and may serve as potential drug targets for the development of disease treatments.
    The FPR1 inhibitor market has shown a steady development trend in recent years. With in-depth research on the biological functions of FPR1 (Formyl Peptide Receptor 1), its key role in inflammatory response, cell migration, cancer development and other processes has been gradually revealed, which has promoted the development and application of FPR1 inhibitors. FPR1 inhibitors are mainly used in scientific research experiments, especially in drug discovery and mechanism research, playing an important role. They provide researchers with tools to regulate FPR1 function to gain insights into related physiological processes and develop novel treatments. In summary, the FPR1 inhibitor market has broad development prospects and huge market potential.
    This report is a detailed and comprehensive analysis for global FPR1 Inhibitor market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global FPR1 Inhibitor market size and forecasts, in consumption value ($ Million), sales quantity (g), and average selling prices (US$/mg), 2021-2032
    Global FPR1 Inhibitor market size and forecasts by region and country, in consumption value ($ Million), sales quantity (g), and average selling prices (US$/mg), 2021-2032
    Global FPR1 Inhibitor market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (g), and average selling prices (US$/mg), 2021-2032
    Global FPR1 Inhibitor market shares of main players, shipments in revenue ($ Million), sales quantity (g), and ASP (US$/mg), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for FPR1 Inhibitor
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global FPR1 Inhibitor market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Bio-Techne, Abcam, ApexBio Technology, TargetMol Chemicals, GLPBio, ProbeChem Biochemicals, MedChemExpress, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    FPR1 Inhibitor market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    FPR1 Antagonists
    Indirect Inhibitors
    Antibody Blockers
    Others
    Market segment by Application
    Pharma/Biotech
    Research
    Other
    Major players covered
    Merck
    Bio-Techne
    Abcam
    ApexBio Technology
    TargetMol Chemicals
    GLPBio
    ProbeChem Biochemicals
    MedChemExpress
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe FPR1 Inhibitor product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of FPR1 Inhibitor, with price, sales quantity, revenue, and global market share of FPR1 Inhibitor from 2021 to 2026.
    Chapter 3, the FPR1 Inhibitor competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the FPR1 Inhibitor breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and FPR1 Inhibitor market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of FPR1 Inhibitor.
    Chapter 14 and 15, to describe FPR1 Inhibitor sales channel, distributors, customers, research findings and conclusion.

    Buy now